Tedeff Cancer Model
Tedeff Cancer Model - Related Videos
08:23
In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model
0 Views •
Cited by 10 •
2016
This video article shows the use of the dorsal root ganglia (DRG)/cancer cell model in pancreatic ductal adenocarcinoma.
08:11
An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis
0 Views •
Cited by 83 •
2016
An orthotopic breast cancer primary tumor model and surgical removal of primary tumor to extend mouse life to generate spontaneous metastasis are described. The tumor growth and progression are monitored and quantified by luciferase fluorescence imaging.
06:01
A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
0 Views •
Cited by 3 •
2017
A protocol for the establishment of a genetically engineered mouse model of colorectal cancer by segmental adeno-cre infection and its surveillance via high-resolution colonoscopy is presented.
03:19
Generating PDOX Mouse Model of Colorectal Cancer: Studying Progression of Colorectal Cancer in a Murine Model
0 Views •
2023
This video describes the protocol for generating a patient-derived orthotopic xenograft colorectal cancer mouse model to study the progression of colorectal cancer cells in non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice. This murine model helps in understanding primary tumor growth and metastases pattern.
08:43
Orthotopic Mouse Model of Colorectal Cancer
0 Views •
Cited by 109 •
2007
Two techniques can be used to establish this model: injection of a cancer cell suspension into the cecal wall or transplantation of a piece of subcutaneous tumor onto the cecum. This model is useful for studying the natural progression of colorectal cancer and testing new therapeutic agents against colorectal cancer.
FAQs
The model links a defined change in a cancer-associated gene with measurable outcomes under controlled biological conditions. Investigators can then compare the altered state with a normal or reference state and determine whether the genetic change corresponds to abnormal cell growth, tumor formation, or a modified treatment response. This genotype-to-phenotype comparison helps clarify how specific alterations contribute to disease mechanisms.
Studying mutations together allows researchers to examine whether genetic alterations act independently, influence one another, or produce combined effects. The model provides a controlled framework for comparing individual and interacting changes through measurable phenotypes. These comparisons can reveal relationships among cancer-associated genes and help explain why particular combinations may alter tumor development or progression.
Controlled biological conditions make comparisons between normal and cancer-associated states more reproducible. When investigators evaluate defined genetic changes within the same experimental framework, differences in cell growth, tumor formation, or treatment response can be linked more directly to genotype. This consistency supports clearer interpretation of disease mechanisms and improves comparisons across genetic conditions.
Researchers can compare treatment responses in systems carrying cancer-associated genetic changes with responses in normal or reference systems. A difference in outcome may indicate that a particular alteration influences treatment sensitivity or resistance within the tested conditions. Such findings can help identify genetic factors relevant to therapeutic targeting and provide context for precision medicine studies.
A study begins by selecting defined changes in cancer-associated genes and establishing the relevant normal and altered biological states. Investigators then maintain these states under controlled conditions, measure outcomes such as abnormal growth, tumor formation, or treatment response, and compare the results. This workflow connects the tested genotype with a reproducible phenotype and supports mechanistic interpretation.
The framework can support investigations of tumor biology, cancer susceptibility, and precision medicine. Researchers may use it to ask how particular genetic alterations contribute to disease development, whether mutations interact, or how genotype affects treatment response. Because the system supports comparisons between normal and cancer-associated states, it can also help evaluate potential therapeutic targets.